Regeneron Pharmaceuticals, Inc.
2020 Q2 - 2025 Q4 (23 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/11/2026 | 19,952 | 0.3% | 25,849 | 12/31/2025 |
| 2025 Q3 | 11/6/2025 | 14,780 | 0.2% | 26,287 | 9/30/2025 |
| 2025 Q2 | 8/7/2025 | 12,436 | 0.2% | 23,688 | 6/30/2025 |
| 2025 Q1 | 4/24/2025 | 13,850 | 0.2% | 21,837 | 3/31/2025 |
| 2024 Q4 | 2/4/2025 | 13,579 | 0.2% | 19,063 | 12/31/2024 |
| 2024 Q3 | 11/4/2024 | 25,432 | 0.4% | 24,192 | 9/30/2024 |
| 2024 Q2 | 8/5/2024 | 25,180 | 0.4% | 23,957 | 6/30/2024 |
| 2024 Q1 | 5/7/2024 | 25,822 | 0.4% | 26,828 | 3/31/2024 |
| 2023 Q4 | 2/1/2024 | 24,009 | 0.4% | 27,336 | 12/31/2023 |
| 2023 Q3 | 11/6/2023 | 22,613 | 0.4% | 27,478 | 9/30/2023 |
| 2023 Q2 | 8/3/2023 | 18,538 | 0.4% | 25,800 | 6/30/2023 |
| 2023 Q1 | 5/5/2023 | 26,047 | 0.6% | 31,700 | 3/31/2023 |
| 2022 Q4 | 2/3/2023 | 24,912 | 0.6% | 34,528 | 12/31/2022 |
| 2022 Q3 | 11/3/2022 | 22,263 | 0.5% | 32,318 | 9/30/2022 |
| 2022 Q2 | 8/5/2022 | 20,973 | 0.5% | 35,480 | 6/30/2022 |
| 2022 Q1 | 4/29/2022 | 5,698 | 0.2% | 8,158 | 3/31/2022 |
| 2021 Q4 | 1/31/2022 | 7,445 | 0.2% | 11,789 | 12/31/2021 |
| 2021 Q3 | 10/28/2021 | 4,282 | 0.2% | 7,076 | 9/30/2021 |
| 2021 Q2 | 8/4/2021 | 4,777 | 0.2% | 8,553 | 6/30/2021 |
| 2021 Q1 | 4/27/2021 | 3,963 | 0.2% | 8,375 | 3/31/2021 |
| 2020 Q4 | 2/9/2021 | 3,297 | 0.2% | 6,825 | 12/31/2020 |
| 2020 Q3 | 11/3/2020 | 1,105 | 0.1% | 1,974 | 9/30/2020 |
| 2020 Q2 | 8/3/2020 | 707 | 0.3% | 1,134 | 6/30/2020 |